UBS Group’s Viemed Healthcare VMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.31M | Buy |
189,417
+93,132
| +97% | +$644K | ﹤0.01% | 4151 |
|
|
2025
Q1 | $701K | Buy |
96,285
+62,893
| +188% | +$458K | ﹤0.01% | 4447 |
|
|
2024
Q4 | $268K | Buy |
33,392
+16,109
| +93% | +$129K | ﹤0.01% | 5088 |
|
|
2024
Q3 | $127K | Buy |
17,283
+5,725
| +50% | +$42K | ﹤0.01% | 5007 |
|
|
2024
Q2 | $75.7K | Sell |
11,558
-25,885
| -69% | -$170K | ﹤0.01% | 5229 |
|
|
2024
Q1 | $353K | Sell |
37,443
-861
| -2% | -$8.12K | ﹤0.01% | 4332 |
|
|
2023
Q4 | $301K | Buy |
38,304
+19,910
| +108% | +$156K | ﹤0.01% | 4333 |
|
|
2023
Q3 | $124K | Sell |
18,394
-5,960
| -24% | -$40.1K | ﹤0.01% | 4583 |
|
|
2023
Q2 | $238K | Buy |
24,354
+20,063
| +468% | +$196K | ﹤0.01% | 4341 |
|
|
2023
Q1 | $41.5K | Buy |
4,291
+1,844
| +75% | +$17.8K | ﹤0.01% | 5502 |
|
|
2022
Q4 | $18.5K | Buy |
2,447
+1,590
| +186% | +$12K | ﹤0.01% | 6556 |
|
|
2022
Q3 | $5K | Buy |
+857
| New | +$5K | ﹤0.01% | 8128 |
|
|
2022
Q2 | – | Sell |
-5,174
| Closed | -$26K | – | 9781 |
|
|
2022
Q1 | $26K | Sell |
5,174
-10,386
| -67% | -$52.2K | ﹤0.01% | 6120 |
|
|
2021
Q4 | $81K | Buy |
+15,560
| New | +$81K | ﹤0.01% | 5413 |
|
|
2021
Q2 | – | Sell |
-11,096
| Closed | -$112K | – | 8614 |
|
|
2021
Q1 | $112K | Sell |
11,096
-5,801
| -34% | -$58.6K | ﹤0.01% | 4895 |
|
|
2020
Q4 | $131K | Sell |
16,897
-11,978
| -41% | -$92.9K | ﹤0.01% | 4538 |
|
|
2020
Q3 | $249K | Buy |
28,875
+15,126
| +110% | +$130K | ﹤0.01% | 3862 |
|
|
2020
Q2 | $132K | Buy |
13,749
+12,466
| +972% | +$120K | ﹤0.01% | 4292 |
|
|
2020
Q1 | $6K | Sell |
1,283
-727
| -36% | -$3.4K | ﹤0.01% | 6317 |
|
|
2019
Q4 | $12K | Buy |
+2,010
| New | +$12K | ﹤0.01% | 6123 |
|